HB-EGF mimics EGF in EGFR signaling, and since HER2+ BC was demonstrated to induce NF-κB [34], which activates TWIST1 expression [17], HB-EGF might support a positive feedback loop in HER2+ BC. Here, ERBB2 is linked to breast cancer.